Guizhou Wansheng Pharmaceutical

Guizhou Wansheng Pharmaceutical is a China-based pharmaceutical manufacturer and a key subsidiary of Guizhou Bailing Group Pharmaceutical. The company focuses on the production of a diverse range of pharmaceutical products, including traditional Chinese medicine (TCM) formulations and chemical generic drugs. Its manufacturing facilities are GMP-certified and capable of producing multiple dosage forms such as tablets, capsules, and granules. Guizhou Wansheng's portfolio addresses various medical needs, particularly in cardiovascular, respiratory, and anti-infective therapies. Since its acquisition by Guizhou Bailing in 2010, it has played a vital role in the parent company's supply chain and market expansion within the Guizhou province and across China.